Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Sep 30, 2024 | (FY)Sep 30, 2023 | (FY)Sep 30, 2022 | (FY)Sep 30, 2021 | (FY)Sep 30, 2020 | (FY)Sep 30, 2019 | (FY)Sep 30, 2018 | |
---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | |||||||
Cash from operating activities | 226.07%593.52M | -63.40%182.02M | 20.22%497.32M | -25.46%413.66M | 14.29%554.95M | 44.33%485.57M | 336.43M |
Net profit before non-cash adjustment | 52.26%587.57M | -19.31%385.89M | -11.36%478.25M | 35.50%539.55M | 3.06%398.18M | -17.88%386.36M | --470.5M |
Total adjustment of non-cash items | 66.77%-60.03M | -3,134.63%-180.62M | -96.51%5.95M | 400.54%170.53M | -47.68%34.07M | 272.95%65.11M | --17.46M |
-Depreciation and amortization | 14.90%78.6M | 40.34%68.41M | 37.45%48.75M | 17.66%35.46M | -0.60%30.14M | -2.50%30.33M | --31.1M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | --31.66M | ---- | ---- | ---- |
-Share of associates | ---23.15M | --0 | ---- | ---- | ---- | ---- | ---- |
-Disposal profit | 6.51%-110.82M | -374.04%-118.53M | -1,464.90%-25.01M | --1.83M | ---- | ---- | --7.16M |
-Other non-cash items | 96.42%-4.67M | -633.59%-130.5M | -117.51%-17.79M | 2,486.53%101.57M | -88.71%3.93M | 267.22%34.79M | ---20.8M |
Changes in working capital | 383.80%65.97M | -277.17%-23.25M | 104.43%13.12M | -341.58%-296.42M | 259.79%122.7M | 122.51%34.1M | ---151.53M |
-Change in receivables | 171.08%61.49M | -160.80%-86.5M | 165.85%142.28M | -331.23%-216.08M | 32.07%93.45M | 138.75%70.76M | ---182.62M |
-Change in inventory | -119.82%-13.28M | 190.92%67.01M | 29.82%-73.7M | -1,639.91%-105.02M | -1,745.87%-6.04M | 95.66%-327K | ---7.53M |
-Change in payables | 306.32%11.11M | 91.00%-5.38M | -396.73%-59.8M | -35.89%20.15M | 184.15%31.44M | -182.12%-37.36M | --45.49M |
-Provision for loans, leases and other losses | 308.90%6.67M | -62.44%1.63M | -4.11%4.34M | 17.62%4.53M | 273.96%3.85M | 114.99%1.03M | ---6.87M |
Dividends paid (cash flow from operating activities) | |||||||
Dividends received (cash flow from operating activities) | |||||||
Interest paid (cash flow from operating activities) | 88.53%-100K | -872K | |||||
Interest received (cash flow from operating activities) | -15.11%30.57M | 4.66%36.02M | 502.47%34.41M | 231.13%5.71M | -4.06%1.73M | -66.26%1.8M | 5.33M |
Tax refund paid | 23.77%-119.66M | 16.97%-156.96M | -10.31%-189.05M | -35.38%-171.38M | 38.29%-126.59M | -206.09%-205.12M | -67.01M |
Other operating cash inflow (outflow) | 0 | -1K | 0 | 0 | 0 | 0 | 16.53M |
Operating cash flow | 725.94%504.44M | -82.18%61.07M | 38.18%342.68M | -42.34%248M | 52.43%430.09M | -2.84%282.15M | --290.4M |
Investing cash flow | |||||||
Net PPE purchase and sale | 14.93%-11.65M | 37.07%-13.69M | 56.75%-21.76M | -341.11%-50.3M | -183.94%-11.4M | 98.12%-4.02M | ---213.75M |
Net intangibles purchase and sale | 98.66%-2.18M | -121.18%-163.18M | 1.64%-73.78M | -331.49%-75.01M | -295.97%-17.38M | 65.13%-4.39M | ---12.59M |
Net investment product transactions | -358.07%-89.8M | 110.17%34.8M | 24.24%-342.31M | ---451.83M | ---- | ---- | --458.53M |
Dividends received (cash flow from investment activities) | --23.15M | --0 | ---- | ---- | ---- | ---- | ---- |
Net changes in other investments | 221.81%266.5M | -404.36%-218.79M | -1,756.95%-43.38M | 105.01%2.62M | -99.58%1.28M | 19,131.76%305.79M | --1.59M |
Investing cash flow | 151.55%186.01M | 25.01%-360.86M | 16.24%-481.22M | -1,988.48%-574.52M | -109.25%-27.51M | 27.20%297.38M | --233.78M |
Financing cash flow | |||||||
Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | -346.32%-343.06M | --139.28M |
Net common stock issuance | 32.47%-52K | ---77K | --0 | --513.6M | ---- | ---- | ---- |
Cash dividends paid | -86.00%-178.19M | 56.99%-95.8M | -223.37%-222.74M | -68.00%-68.88M | 0.00%-41M | 26.36%-41M | ---55.68M |
Net other fund-raising expenses | ---1K | ---- | ---- | ---1K | ---- | ---- | ---- |
Financing cash flow | -85.90%-178.24M | 56.95%-95.88M | -150.08%-222.74M | 1,184.67%444.72M | 89.32%-41M | -559.40%-384.06M | --83.6M |
Net cash flow | |||||||
Beginning cash position | -26.58%1.09B | -19.53%1.49B | 6.83%1.85B | 26.39%1.73B | 16.64%1.37B | 107.22%1.17B | --566.83M |
Current changes in cash | 229.45%512.21M | -9.52%-395.67M | -405.67%-361.28M | -67.31%118.19M | 84.98%361.58M | -67.84%195.47M | --607.79M |
Cash adjustments other than cash changes | ---- | 0.00%-1K | -200.00%-1K | 200.00%1K | -200.00%-1K | --1K | ---- |
End cash Position | 46.87%1.61B | -26.58%1.09B | -19.53%1.49B | 6.83%1.85B | 26.39%1.73B | 16.64%1.37B | --1.17B |
Free cash flow | 523.66%490.61M | -147.47%-115.8M | 98.82%243.93M | -69.43%122.69M | 46.60%401.31M | 327.32%273.75M | --64.06M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |